DE69206607D1 - Behandlung von kognitiven störungen. - Google Patents

Behandlung von kognitiven störungen.

Info

Publication number
DE69206607D1
DE69206607D1 DE69206607T DE69206607T DE69206607D1 DE 69206607 D1 DE69206607 D1 DE 69206607D1 DE 69206607 T DE69206607 T DE 69206607T DE 69206607 T DE69206607 T DE 69206607T DE 69206607 D1 DE69206607 D1 DE 69206607D1
Authority
DE
Germany
Prior art keywords
treatment
cognitive disorders
patient
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69206607T
Other languages
English (en)
Other versions
DE69206607T2 (de
Inventor
Jens Kristian Perregaard
Brenda Costall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of DE69206607D1 publication Critical patent/DE69206607D1/de
Publication of DE69206607T2 publication Critical patent/DE69206607T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Meat And Fish (AREA)
DE69206607T 1991-03-01 1992-02-28 Behandlung von kognitiven störungen. Expired - Fee Related DE69206607T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
PCT/DK1992/000063 WO1992015303A1 (en) 1991-03-01 1992-02-28 Treatment of cognitive disorders

Publications (2)

Publication Number Publication Date
DE69206607D1 true DE69206607D1 (de) 1996-01-18
DE69206607T2 DE69206607T2 (de) 1996-05-15

Family

ID=8092662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69206607T Expired - Fee Related DE69206607T2 (de) 1991-03-01 1992-02-28 Behandlung von kognitiven störungen.

Country Status (17)

Country Link
US (1) US5444073A (de)
EP (1) EP0575429B1 (de)
JP (1) JP3108434B2 (de)
KR (1) KR0183424B1 (de)
AT (1) ATE131055T1 (de)
AU (1) AU663699B2 (de)
CA (1) CA2105385C (de)
CY (1) CY2083B1 (de)
DE (1) DE69206607T2 (de)
DK (2) DK36291D0 (de)
HK (1) HK1003560A1 (de)
IE (1) IE70600B1 (de)
IL (1) IL101102A (de)
NO (1) NO307406B1 (de)
NZ (1) NZ241800A (de)
WO (1) WO1992015303A1 (de)
ZA (1) ZA921462B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
US9174975B2 (en) 2002-08-22 2015-11-03 Sumitomo Dainippon Pharma Co., Ltd Remedy for integration dysfunction syndrome
US20060142276A1 (en) * 2003-06-23 2006-06-29 Yukihiro Ohno Therapeutic agent for senile dementia
EP2357474A1 (de) 2004-02-20 2011-08-17 Dainippon Sumitomo Pharma Co., Ltd. Lurasidon zur Verwendung in der Behandlung von Gedächtnis- oder Lernstörungen bei Schizophrenie
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
SE8004129L (sv) * 1979-07-13 1981-01-14 Roussel Uclaf Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater

Also Published As

Publication number Publication date
AU1370792A (en) 1992-10-06
DK36291D0 (da) 1991-03-01
KR930702978A (ko) 1993-11-29
JP3108434B2 (ja) 2000-11-13
US5444073A (en) 1995-08-22
NO307406B1 (no) 2000-04-03
IE920572A1 (en) 1992-09-09
IE70600B1 (en) 1996-12-11
CA2105385C (en) 2000-08-15
DE69206607T2 (de) 1996-05-15
NO933091D0 (no) 1993-08-31
IL101102A (en) 1996-03-31
AU663699B2 (en) 1995-10-19
ZA921462B (en) 1992-11-25
CY2083B1 (en) 1998-10-16
EP0575429A1 (de) 1993-12-29
NO933091L (no) 1993-11-01
IL101102A0 (en) 1992-11-15
KR0183424B1 (ko) 1999-05-01
JPH06504787A (ja) 1994-06-02
HK1003560A1 (en) 1998-10-30
EP0575429B1 (de) 1995-12-06
CA2105385A1 (en) 1992-09-02
WO1992015303A1 (en) 1992-09-17
DK0575429T3 (da) 1996-04-22
ATE131055T1 (de) 1995-12-15
NZ241800A (en) 1997-03-24

Similar Documents

Publication Publication Date Title
NO974163L (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
MY117896A (en) Quinazoline derivatives
ATE189218T1 (de) Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren
NO944018L (no) Behandling av makulær degenerasjon
FI102964B1 (fi) Terapeuttisia yhdisteitä
ATE131055T1 (de) Behandlung von kognitiven störungen.
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
ATE152708T1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
MY133438A (en) Morpholinobenzamide salts
DE69906728D1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
DE69117923D1 (de) Pharmazeutische zusammensetzungen zur aids-behandlung
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE254919T1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee